SpyGlass Pharma Inc (SGP) Stock Price & News

All values in USD	Jun 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	7.33M	7.71M	8.54M	10.94M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.96M	5.92M	6.87M	11.02M
Operating expense	9.30M	13.63M	15.41M	21.97M
Total operating expenses	9.30M	13.63M	15.41M	21.97M
Operating income	-9.30M	-13.63M	-15.41M	-21.97M
Other non operating income	-	11.00	-	-
EBT including unusual items	-8.68M	-12.56M	-13.82M	-19.86M
EBT excluding unusual items	-8.68M	-12.56M	-13.82M	-19.86M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-8.68M	-12.56M	-13.82M	-19.86M
Net profit margin	-	-	-	-
Earnings per share	-	-	-0.69	-0.59
Interest and investment income	622.00K	1.07M	1.59M	2.10M
Interest expense	-	-	-	-
Net interest expenses	622.00K	1.07M	1.59M	2.10M
Depreciation and amortization charges	-	-	-	-
EBITDA	-9.16M	-13.41M	-15.09M	-21.62M
Gain or loss from assets sale	4.00K	1.10K	-	-

Finance